Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.71 USD | +12.14% | +7.05% | -5.99% |
05-03 | Abeona Therapeutics Prices $75 Million Securities Offering; Shares Rise | MT |
04-23 | Sector Update: Health Care Stocks Rise Late Afternoon | MT |
Sales 2024 * | 500K 680K | Sales 2025 * | 22.83M 31.04M | Capitalization | 187M 254M |
---|---|---|---|---|---|
Net income 2024 * | -60M -81.59M | Net income 2025 * | -63M -85.67M | EV / Sales 2024 * | 373 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 8.18 x |
P/E ratio 2024 * |
-2.2
x | P/E ratio 2025 * |
-2.48
x | Employees | 84 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 94.91% |
Latest transcript on Abeona Therapeutics Inc.
1 day | +12.14% | ||
1 week | +7.05% | ||
Current month | +13.77% | ||
1 month | -38.35% | ||
3 months | -27.43% | ||
6 months | +13.49% | ||
Current year | -5.99% |
Managers | Title | Age | Since |
---|---|---|---|
Vishwas Seshadri
CEO | Chief Executive Officer | 48 | 21-05-31 |
Michael Amoroso
CHM | Chairman | 46 | 20-07-08 |
Joseph Vazzano
DFI | Director of Finance/CFO | 40 | 22-03-13 |
Members of the board | Title | Age | Since |
---|---|---|---|
Mark Alvino
BRD | Director/Board Member | 56 | 06-02-28 |
Faith Charles
BRD | Director/Board Member | 62 | 21-03-24 |
Leila Alland
BRD | Director/Board Member | 61 | 21-04-18 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-15 | 4.71 | +12.14% | 1,101,517 |
24-05-14 | 4.2 | -2.33% | 955,320 |
24-05-13 | 4.3 | +2.38% | 534,292 |
24-05-10 | 4.2 | -5.62% | 1,086,831 |
24-05-09 | 4.45 | +1.14% | 526,684 |
Delayed Quote Nasdaq, May 15, 2024 at 04:00 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-5.99% | 115M | |
+29.77% | 49.18B | |
+1.00% | 42.11B | |
+50.47% | 40.37B | |
-5.26% | 28.85B | |
+13.68% | 26.09B | |
-22.99% | 18.71B | |
+8.22% | 13.26B | |
+32.41% | 12.32B | |
-1.62% | 11.99B |
- Stock Market
- Equities
- ABEO Stock